SGCG and melanoma: Other recent studies have examined the response of T and NK lymphocytes from melanoma patients to type I and type II interferons (IFN), where a defective activation of STAT1 in response to IFN-α and IFN-γ was found in some lymphocyte subsets relative to healthy controls [29, 30].